IDENTIFICATION OF PREDICTIVE BIOMARKERS AND COMBINATORIAL TREATMENTS FOR AML USING AN ADVANCED CRISPR/CAS9 SCREENING PLATFORM

EHA Library, Johannes Schmoellerl, 420522

ABSENCE OF STAT3Β CONTRIBUTES TO ADVERSE OUTCOME IN ACUTE MYELOID LEUKEMIA BY ENHANCING THE INTERFERON RESPONSE

EHA Library, Sophie Edtmayer, 420523

MULTICENTER RETROSPECTIVE OBSERVATORY OF ACUTE MYELOID LEUKEMIA PATIENTS WITH NUP98 REARRANGEMENT. A STUDY FROM THE ALFA-FILO FRENCH AML INTERGROUP.

EHA Library, Benoît Ducourneau, 420524

MLLT1/3 TARGETED AGENTS AS NOVEL INHIBITORS OF THE SUPER-ELONGATION COMPLEX (SEC) TO TREAT MOLECULARLY DEFINED ACUTE LEUKEMIA INCLUDING MENIN-INHIBITOR RESISTANT AND REFRACTORY DISEASE.

EHA Library, Alison Maloney, 420525

BRD4 DEGRADATION AS A NOVEL STRATEGY TO OVERCOME INTRINSIC, ACQUIRED, NICHE-INDUCED AND CHECKPOINT-MEDIATED RESISTANCE IN AML AND ALL

EHA Library, Karin Bauer, 420527

INVESTIGATION OF THE REGULATORS OF NUP98 FUSION ONCOPROTEIN HOMEOSTASIS

EHA Library, Ecem Kirkiz, 420528

IDENTIFICATION OF ZFP91 AS THE MASTER TRANSCRIPTION FACTOR FOR EVI1 GENE EXPRESSION IN MYELOID LEUKEMIA

EHA Library, Hiroki Hayashida, 420529

(R)-WAC-224, A NOVEL ANTICANCER QUINOLONE AND VENETOCLAX PLUS AZACITIDINE OVERCOME VENETOCLAX-RESISTANT AML VIA DOWNREGULATION OF MCL-1

EHA Library, Hiroshi Ureshino, 420530

PROTEOMIC ANALYSIS BY OLINK INFLAMMATION PLATFORM PREDICTED THE CHEMORESITANCE IN AML UNDER 7+3

EHA Library, Ling-Chiao Teng, 420531

SINGLE-CELL COMPUTER VISION UNVEILS DISCRIMINATIVE FEATURES OF LATENT CELLULAR MORPHOLOGY IN MYELOID CLONAL HEMATOPOIESIS

EHA Library, Helong Zhao, 420532

INTERPLAY BETWEEN MACROPHAGES AND AML BLASTS IN PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Alicia Perzolli, 420533

ENHANCING THE EFFICACY OF P53-Y220C REACTIVATOR PC14586 BY COMBINATION WITH MDM2 OR BCL-2 INHIBITORS IN TP53-Y220C AML

EHA Library, Bing Carter, 420534

ACUTE MYELOID LEUKEMIA-MODIFIED BONE MARROW ENDOTHELIAL PROGENITOR CELLS COULD BE REMODELED TO FACILITATE RECOVERY OF NORMAL HEMATOPOIESIS AFTER COMPLETE REMISSION

EHA Library, Tong Xing, 420535

GENOMIC LANDSCAPE AND CLONAL HEMATOPOIESIS DYNAMICS IN PATIENTS WITH EPITHELIAL OVARIAN CANCER (EOC) DURING PARP INHIBITORS TREATMENT: PRELIMINARY RESULTS OF A PROSPECTIVE LONGITUDINAL STUDY

EHA Library, Elisabetta Todisco, 420536

CD37 IS A RELEVANT TARGET FOR AML AND MDS TREATMENT BY DEBIO 1562M ANTIBODY DRUG CONJUGATE (ADC)

EHA Library, Lisa Ivanschitz, 420537

MUTANT U2AF1-INDUCED MIS-SPLICING OF MRNA TRANSLATION GENES CONFERS RESISTANCE TO CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA

EHA Library, Peng Jin, 420538

EXPLORING DOSE-RESPONSE RELATIONSHIP OF A NOVEL CD123 NK CELL ENGAGER SAR443579 IN ACUTE MYELOID LEUKEMIA (AML) MODELS

EHA Library, Angela Virone-Oddos, 420539

THE DIFFERENTIAL ROLE OF STAT3 AND STAT5 FACTORS IN LEUKEMIC TRANSFORMATION FROM MDS TO AML

EHA Library, Eirini Sofia Fasouli, 420540

IDENTIFICATION OF FUNCTIONALLY ACTIVE AND ESSENTIAL ENHANCERS IN ACUTE MYELOID LEUKAEMIA

EHA Library, Bettina Wingelhofer, 420541

THE BISPECIFIC INNATE CELL ENGAGER AFM28 INDUCES POTENT ANTI-TUMOR ACTIVITY AGAINST AML IN A XENOGRAFT MOUSE MODEL AND IN A BONE MARROW NICHE IN VITRO MODEL

EHA Library, Ioanna Tsoukala, 420542

SINGLE-CELL GUIDED IMMUNE DECONVOLUTION IDENTIFIES CHEMOTHERAPY-ASSOCIATED ALTERATIONS OF THE BONE MARROW IMMUNE MICROENVIRONMENT IN PEDIATRIC AML

EHA Library, Joost Koedijk, 420543

TRANSCRIPTION FACTOR MYBL2 ACTS AS A MOLECULAR SWITCH BETWEEN PROLIFERATION AND SENESCENCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Sandra Schuster, 420544

SINGLE-CELL TRANSCRIPTOMICS REVEALS T CELL EXHAUSTION IN SUPPRESSIVE MARROW IMMUNE MICROENVIRONMENT OF RESIDUAL DISEASE POSITIVE PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC TRANSPLANTATION

EHA Library, Siqi Li, 420545

MOLECULAR BACKTRACKING OF LEUKEMIC CELLS IN CRYOPRESERVED OVARIAN TISSUE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Augustin Boudry, 420546

CEBPA MUTATIONAL SPECTRUM AND ITS CLINICAL IMPLICATIONS IN AML VERSUS MDS – RETROSPECTIVE REAL WORLD STUDY OF CEBPA-MUTATED PATIENTS

EHA Library, Katrin Schweneker, 420547

INDUCTION OF AML CELL DEATH AND DIFFERENTIATION USING HOXA9/DNA BINDING INHIBITORS DB818 AND DB1055 AS A POTENTIAL THERAPEUTIC OPTION FOR AML PATIENTS.

EHA Library, Marie-Helene David-Cordonnier, 420548

M6A RNA MODIFICATION INITIATED BY METTL3 PROMOTES FOXO3 EXPRESSION TO INDUCE ANTHRACYCLINE RESISTANCE IN ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Xiawei Zhang, 420549

INHIBITION OF PINK1-MEDIATED MITOPHAGY POTENTIATES VENETOCLAX ACTIVITY IN ACUTE MYELOID LEUKEMIA.

EHA Library, Romain Vazquez, 420550

UBE2Q1 IMPAIRS ANTIGEN PRESENTATION IN AML

EHA Library, Xiaoxuan Yu, 420551

CLINICAL SIGNIFICANCE OF NPM1 SUBGROUPS IN THE DIAGNOSIS OF AML PATIENTS

EHA Library, Wencke Walter, 420552

CSF1R MARKS A SUBSET OF FETAL LMPP WITH ACUTE MYELOID LEUKEMIA PROPAGATION PROPERTIES IN A MLL-AF9 MOUSE MODEL

EHA Library, Giuseppina Camiolo, 420553

UNRAVELING CLONAL EVOLUTION AND MECHANISMS OF TREATMENT RESISTANCE IN MURINE KMT2A-REARRANGED LEUKEMIA WITH SUBCLONAL FLT3N676K

EHA Library, Ton Falqués-Costa, 420554

NOVEL VHH-BASED CAR-T CELLS AGAINST CD33 WITH DIFFERENT AFFINITIES PRESENT IMPROVED EFFICACY FOR THE TREATMENT OF AML

EHA Library, Franco Bernasconi Bisio, 420555

THE TGFΒ SIGNALING PARADOX IN AML: A SYSTEMATIC CRISPRI-BASED SCREENING APPROACH TO OVERCOME DRUG RESISTANCE

EHA Library, Elahe Rahimian, 420556

CCRL2 PROMOTES MALIGNANT CELL GROWTH AND INDUCES STAT1 SIGNALING IN ERYTHROLEUKEMIA

EHA Library, Nour Naji, 420557

SELECTIVE ABLATION OF CXCR4+ AML PATIENT CELLS IN VITRO AND INHIBITION OF LEUKEMIA DISSEMINATION IN VIVO BY A MULTIVALENT MMAE-BASED HUMANIZED NANOCONJUGATE

EHA Library, Annabel Garcia León, 420558

PP2A- BASED THERAPEUTIC STRATEGIES FOR KMT2A-REARRANGED LEUKAEMIA

EHA Library, Maria Teresa Esposito, 420559

TRANSFERRIN IN COMBINATION WITH INDUCTION CHEMOTHERAPY IMPROVES OUTCOMES IN AN IMMUNOCOMPETENT MOUSE MODEL OF ACUTE MYELOID LEUKEMIA

EHA Library, Marta Lopes, 420560

NOVEL EPIGENETIC BASED DIFFERENTIATION THERAPY FOR ACUTE MYELOID LEUKEMIA

EHA Library, Edurne San Jose-Eneriz, 420561

SYNERGISTIC ROLE OF ALDEHYDE DEHYDROGENASE INHIBITION AND HYPOMETHYLATING AGENTS IN RELAPSE/REFRACTORY AML

EHA Library, Mehak Shaikh, 420562

PI3K ACTIVATION REGULATES LEUKAEMIA ASSOCIATED MACROPHAGE POLARISATION IN THE AML TUMOUR MICROENVIRONMENT

EHA Library, George Bell, 420563

ESTABLISHING A GENETICALLY-DEFINED IN VIVO MODEL FOR PRECISELY INVESTIGATING PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Hasan Issa, 420564

A LEUKEMIC STEM CELL-SPECIFIC CRISPRI SCREEN DEMONSTRATES FUNCTIONAL DIVERSITY OF LONG NON-CODING RNAS IN ACUTE MYELOID LEUKEMIA

EHA Library, Silvia Schäfer, 420565

CHARACTERIZATION OF IMMUNOPHENOTYPIC CHANGES FOLLOWING MENIN INHIBITION IN ACUTE MYELOID LEUKEMIA

EHA Library, Sanam Loghavi, 420566

EVALUATING THE EFFICACY OF PATIENT-ORIENTED COMBINATION THERAPIES FOR AML VIA EX VIVO AND IN VIVO MODELS

EHA Library, elham gholizadeh, 420567

THE POTENTIAL OF CIRCFN IN MODULATING PML-RARΑ STABILITY AND PROGRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Jiacheng Lou, 420568

GENOME ENGINEERED TET2 LOSS-OF-FUNCTION MUTATIONS INCREASE SELF-RENEWAL AND COMPETITIVE POTENTIAL IN HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS

EHA Library, Erdem Özkaya, 420569

TUMORAL AND NON-TUMORAL INFLUENCE ON NATURAL KILLER CELL IMMUNOSURVEILLANCE DURING MDS PROGRESSION TO SAML

EHA Library, Berenice Schell, 420570

EXPLORING NOVEL CHARACTERISTICS OF LEUKEMIA STEM CELLS: INSIGHTS INTO MITOCHONDRIAL DEPENDENCE.

EHA Library, Maddalena Benetton, 420571

DECIPHERING THE MOLECULAR MECHANISM OF MESENCHYMAL STROMAL CELL MEDIATED DRUG RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, sayantanee Dutta, 420572

AUTOPHAGY INHIBITION BOOSTS MIDOSTAURIN EFFICACY ON HYPOXIC LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA

EHA Library, Samantha Bruno, 420573

TARGETING O-GLCNAC TRANSFERASE (OGT) AS A NOVEL THERAPEUTIC STRATEGY FOR EVI1+ ACUTE MYELOID LEUKEMIA: ENHANCING MITOCHONDRIAL PRIMING FOR IMPROVED OUTCOMES

EHA Library, Junbum Im, 420574

IDENTIFICATION AND CHARACTERISATION OF PU.1-DRIVEN GENE REGULATORY COMPLEXES AND NETWORKS IN ACUTE MYELOID LEUKAEMIA.

EHA Library, Jaana Bagri, 420575

THE COMBINATION CHLOROQUINE WITH FLT3 INHIBITORS OVERCOMES DRUG RESISTANCE IN FLT3-ITD MUTANT ACUTE MYELOID LEUKEMIA

EHA Library, Manuela Melo, 420576

BIALLELIC MUTATION OF DNMT3A DRIVES METHYLATION DAMAGE AND POOR SURVIVAL IN ACUTE MYELOID LEUKEMIA

EHA Library, Sanne Massaar, 420577

MIR-210 MEDIATED REGULATION OF PD-L1 EXPRESSION VIA THE JAK-STAT PATHWAY IN NPM1-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Leo Escano, 420578

SIMULTANEOUS EVALUATION OF TIM-3+LSC AND LAIP-BASED MRD ENHANCES RELAPSE PREDICTION: A SINGLE-TUBE APPROACH

EHA Library, teppei sakoda, 420579

ANTILEUKEMIC THERAPY WITH DOT1L INHIBITOR DEPENDS ON NORMAL ACTIVITY OF TRANSCRIPTION FACTORS PU.1 AND C/EBPΑ

EHA Library, Monica Cusan, 420580

STING ACTIVATION INDUCES PHAGOCYTIC CLEARANCE OF AML BY MACROPHAGES THROUGH AN ICAM/LFA1-DEPENDENT MECHANISM

EHA Library, Matthew Markham, 420581

HIGH IASPP (PPP1R13L) EXPRESSION IS AN INDEPENDENT PREDICTOR OF CLINICAL OUTCOME IN ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Kerstin Kampa-Schittenhelm, 420582

DUAL TARGETING OF FLT3-ITD AND CLK BY SCREENED DONATED CHEMICAL PROBES IN ACUTE MYELOID LEUKEMIA

EHA Library, Stephanie Laszig, 420583

AZD9829 DEMONSTRATES COMBINATION BENEFIT WITH HMA AND VENETOCLAX IN AML CELL LINES, PATIENT SAMPLES AND PDX MODELS.

EHA Library, Dipannita Dutta, 420584

COMPARISON OF TWO HIERARCHICAL DIRICHLET MIXTURE MODELS FOR THE GENOMIC STRATIFICATION OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Amin Turki, 420586

THE ROLE OF PRC2 IN GENE REGULATION AND CHROMATIN ARCHITECTURE IN ACUTE MYELOID LEUKAEMIA

EHA Library, Cosmin Tudose, 420587

IDENTIFICATION OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR, PAROXETINE, AS A NOVEL THERAPEUTIC AGENT IN MLL-REARRANGED ACUTE MYELOID LEUKAEMIA

EHA Library, Cheuk Yin Yuen, 420588

SYNERGISTIC POTENTIAL OF RVU120, A FIRST-IN-CLASS CDK8/CDK19 INHIBITOR, WITH VENETOCLAX IN AML: PRECLINICAL AND INITIAL CLINICAL INSIGHTS

EHA Library, Urszula Pakulska, 420589

AML LACKING PSAT1 EXPRESSION IS VULNERABLE TO SERINE-DEPLETION STRATEGIES

EHA Library, Ilias Sinanidis, 420590

CELLULAR CONTEXT DETERMINES SENSITIVITY TO ASCORBIC ACID IN AN IDH1-MUTANT ACUTE MYELOID LEUKEMIA MODEL.

EHA Library, Sarah Grasedieck, 420591

GENOME-WIDE ANALYSES IN OVER 363,000 INDIVIDUALS IDENTIFIES NEW MULTI-OMIC DETERMINANTS OF CLONAL HAEMATOPOIESIS AND HEMATOPOIETIC MOSAIC CHROMOSOMAL ALTERATIONS

EHA Library, Jonathan Bowles, 420592

FETAL MLL-ENL INITIATION INDUCES HERITABLE PROTECTIVE TRANSCRIPTIONAL PROGRAMS AGAINST TRANSFORMATION THAT DEPEND ON MLL3

EHA Library, Jonny Mendoza-Castrejon, 420593

NUP98::NSD1 RETAINS STEMNESS OF HEMATOPOIETIC STEM CELLS WITH DIFFERENTIATION BIAS TOWARDS MYELOID LINEAGE LEADING TO ACUTE MYELOID LEUKEMIA

EHA Library, Arunim Shah, 420594

REM-422, A POTENT, SELECTIVE, ORAL SMALL MOLECULE MRNA DEGRADER OF THE MYB ONCOGENE, DEMONSTRATES ANTI-TUMOR ACTIVITY IN MOUSE XENOGRAFT MODELS OF AML

EHA Library, Charles Kung, 420595

HMPL-306 IN PATIENTS WITH RELAPSED OR REFRACTORY MYELOID HEMATOLOGICAL MALIGNANCIES HARBORING IDH1 AND/OR IDH2 MUTATIONS: FINAL RESULT OF DOSE EXPANSION IN PHASE 1 STUDY

EHA Library, Lijuan Hu, 420596

CLINICAL CHARACTERISTICS, GENETIC HETEROGENEITY, AND OUTCOMES OF KMT2A-REARRANGED AML IN ADULTS: A RETROSPECTIVE COHORT STUDY

EHA Library, Li Chen, 420597

COUPLING FUNCTIONAL RESISTANCE MARKERS AND COMPUTATIONAL ANALYSIS TO IMPROVE AND SIMPLIFY FLOW CYTOMETRIC MRD DETECTION IN AML

EHA Library, Nicholas McCarthy, 420598

A PROSPECTIVE, CROSSOVER DESIGN STUDY FOR THE SECONDARY PREVENTION AND TREATMENT OF CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN ACUTE MYELOID LEUKEMIA PATIENTS POST-CYTARABINE CONSOLIDATION CHEMOTHERAPY

EHA Library, Wenlan Chen, 420599

INTERIM SAFETY AND EFFICACY OF BP1001 IN A PHASE II ACUTE MYELOID LEUKEMIA STUDY

EHA Library, Jorge Cortes, 420600

LIPOSOMAL ANNAMYCIN (L-ANN) IN COMBINATION WITH CYTARABINE FOR TREATMENT OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) REFACTORY TO OR RELAPSED (R/R) AFTER INDUCTION THERAPY (MB-106 STUDY).

EHA Library, Wolfram Dempke, 420601

PRELIMINARY SAFETY AND ANTILEUKEMIC ACTIVITY OF SONROTOCLAX (BGB-11417), A POTENT AND SELECTIVE BCL2 INHIBITOR, IN TREATMENT-NAIVE PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Shuhying Tan, 420602

THE ROLE OF INTENSIVE CHEMOTHERAPY IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, Philip Haddad, 420603

SAFETY AND ACTIVITY OF REVUMENIB IN COMBINATION WITH FLUDARABINE/CYTARABINE (FLA) IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LEUKEMIAS

EHA Library, Neerav Shukla, 420604

OVERALL SURVIVAL IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS WITH MIDH1 OR MIDH2 IN THE US, FROM AN INTERNATIONAL REAL-WORLD DATABASE (REAL-IDH)

EHA Library, Joshua Zeidner, 420605

EARLY RESPONSE ASSESSMENT AFTER CPX-351 INDUCTION THERAPY FOR ACUTE MYELOID LEUKEMIA

EHA Library, Julian Ronnacker, 420606

TOLERABILITY AND EFFICACY OF MAGROLIMAB PLUS MITOXANTRONE, ETOPOSIDE, AND CYTARABINE (MEC) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) REFRACTORY/RELAPSED (R/R) AFTER INDUCTION CHEMOTHERAPY (IC)

EHA Library, Gabriel Mannis, 420607

VENETOCLAX PLUS AZACITIDINE, CYTARABINE, ACLARUBICIN AND G-CSF (VA-CAG REGIMEN) FOR NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA: UPDATE OF A PROSPECTIVE, MULTICENTER, PHASE 2 CLINICAL TRIAL

EHA Library, Xiaoping Li, 420608

TREATMENT EFFECTIVENESS OF VENETOCLAX IN COMBINATION WITH HYPOMETHYLATING AGENTS IN PATIENT SUBGROUPS WITH ACUTE MYELOID LEUKEMIA: EXPERIENCE FROM ROUTINE CLINICAL PRACTICES IN THE UNITED STATES

EHA Library, Pankit Vachhani, 420609

OPTIMAL DURATION OF CPX-351 TREATMENT AND BEST TIMING FOR CONSOLIDATION WITH ALLOGENEIC STEM CELL TRANSPLANTATION: EVIDENCE FROM A LARGE REAL-WORLD ITALIAN STUDY.

EHA Library, Fabio Guolo, 420610

PHASE I STUDY OF S65487, A BCL2 INHIBITOR COMBINED WITH AZACITIDINE IN ADULTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Pau Montesinos, 420611

DISMAL OUTCOMES FOLLOWING ALLOGENEIC TRANSPLANTATION IN AML PATIENTS WITH T(16;21)(P11.2;Q22.2)/FUS::ERG TRANSLOCATION

EHA Library, Yi-han Yang, 420612

PHASE 1 STUDY OF HMPL-306 IN PATIENTS WITH ADVANCED ACUTE MYELOID LEUKEMIA WITH ISOCITRATE DEHYDROGENASE (IDH) MUTATIONS: PRELIMINARY RESULTS OF THE DOSE ESCALATION COHORTS

EHA Library, Pau Montesinos, 420613

BASELINE PREDICTORS OF SURVIVAL IN 263 PATIENTS WITH AML TREATED WITH HYPOMETHYLATING AGENTS PLUS VENETOCLAX: A MULTICENTER COHORT STUDY.

EHA Library, Stefano Cordella, 420614

REVUMENIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY KMT2AR ACUTE LEUKEMIA: TOPLINE EFFICACY AND SAFETY RESULTS FROM THE PIVOTAL AUGMENT-101 PHASE 2 STUDY

EHA Library, Ibrahim Aldoss, 420615

BLEEDING PREDICTORS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Nikola Pantic, 420616

REAL-WORLD STUDY OF PATIENTS WITH RELAPSED OR REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH TAGRAXOFUSP

EHA Library, Marco Herling, 420617

PRELIMINARY EFFICACY AND MOLECULAR CHARACTERIZATION OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS WITH FLT3 MUTATION TREATED WITH SINGLE AGENT EMAVUSERTIB (CA-4948)

EHA Library, Eric Winer, 420618

DISTINCT CLINICAL AND BIOLOGICAL CHARACTERISTICS OF ACUTE MYELOID LEUKEMIA WITH HIGHER EXPRESSION OF PIWIL4

EHA Library, Sheng-Yu Hung, 420619

RANDOMIZED PHASE 2 STUDY OF CPX-351 + POMALIDOMIDE VS CPX-351 ALONE IN NEWLY DIAGNOSED AML WITH MDS-RELATED CHANGES: RESULTS OF SAFETY RUN-IN EVALUATION

EHA Library, Daniel Peters, 420620

SAFETY AND EFFICACY OF TUSPETINIB AS MONOTHERAPY AND COMBINED WITH VENETOCLAX IN A PHASE 1/2 TRIAL OF PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Rafael Bejar, 420621

ADULT AND PEDIATRIC DETERMINANTS OF SURVIVAL IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, Philip Haddad, 420622

A MULTI-CENTER, OPEN-LABEL, SINGLE-ARM PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FCN-159 IN ADULTS WITH HISTIOCYTIC NEOPLASMS

EHA Library, Xin-xin Cao, 420623